Profile
Ian Frank Scholes is currently the Chief Executive Officer & Partner at Chord Capital Pty Ltd. He previously worked as the Vice Chairman-Investment Banking at Merrill Lynch (Australia) Pty Ltd. He was also the Deputy Chairman at Mayne Pharma Group Ltd. from 2021 to 2022.
He served as a Non-Executive Director at Halcygen Pharmaceuticals Ltd. from 2007 to 2010.
In addition, he was an Independent Non-Executive Director at SDI Ltd. in 2013.
He also worked as an Executive General Manager at National Australia Bank Ltd. Mr. Scholes received his undergraduate degree from the University of Melbourne.
Ian Scholes active positions
| Companies | Position | Start |
|---|---|---|
Chord Capital Pty Ltd. | Chief Executive Officer | - |
Former positions of Ian Scholes
| Companies | Position | End |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Director/Board Member | 30/09/2022 |
| SDI LIMITED | Director/Board Member | 02/08/2013 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics | Director/Board Member | 22/11/2010 |
Merrill Lynch (Australia) Pty Ltd.
Merrill Lynch (Australia) Pty Ltd. Financial ConglomeratesFinance Provides online lease financing services | Corporate Officer/Principal | - |
St. Vincent Health, Inc.
St. Vincent Health, Inc. Hospital/Nursing ManagementHealth Services Operates general hospitals and specialty hospitals | Director/Board Member | - |
Training of Ian Scholes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
National Australia Bank Ltd.
National Australia Bank Ltd. Major BanksFinance Provides banking services | Finance |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics | Health Technology |
SDI Ltd.
SDI Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets specialist dental restorative materials | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Vincent Health, Inc.
St. Vincent Health, Inc. Hospital/Nursing ManagementHealth Services Operates general hospitals and specialty hospitals | Health Services |
Merrill Lynch (Australia) Pty Ltd.
Merrill Lynch (Australia) Pty Ltd. Financial ConglomeratesFinance Provides online lease financing services | Finance |
Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Chord Capital Pty Ltd. |
- Stock Market
- Insiders
- Ian Scholes
















